Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Astrazeneca Plc ADR (AZN)

Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Healthcare - stethoscope-with-injection-protective-mask-lying-over-medical-chart-SBI-300904603
Forget Weight-Loss Drugs, Here's the Next Breakthrough Pharma Stock Barchart - Mon May 13, 6:30AM CDT

There is another segment of the pharma industry that is as hot as weight-loss drugs: antibody-drug conjugates, or ADCs. These treatments will, in the near future, replace conventional chemotherapy, thanks...

PFE : 28.64 (-0.97%)
ABBV : 166.42 (+1.26%)
JNJ : 154.64 (+0.23%)
RHHBY : 32.8100 (+0.49%)
GMAB : 29.98 (+1.11%)
AZN : 76.90 (-0.18%)
DSNKY : 35.4950 (+1.47%)
MRK : 131.19 (+0.24%)
LLY : 770.00 (-0.15%)
NVO : 131.89 (-0.86%)
Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead Motley Fool - Sun May 12, 7:20AM CDT

Johnson & Johnson isn't the ultra-safe stock it used to be.

MMM : 105.26 (+0.38%)
JNJ : 154.64 (+0.23%)
AZN : 76.90 (-0.18%)
Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb Newswire.ca - Thu May 9, 9:22AM CDT

/CNW/ -- In the fight against cancer, a political stumbling block was recently put in place by the US Congress after it voted against the renewal of funding...

ONCY : 1.1100 (-1.77%)
CADL : 11.50 (-9.45%)
AZN : 76.90 (-0.18%)
HALO : 44.71 (-1.50%)
JANX : 47.10 (-0.86%)
ONC.TO : 1.51 (-2.58%)
Rising Cancer Rates Drive Biotech Advancements Despite Political Hurdles BayStreet.ca - Thu May 9, 9:13AM CDT

USA News Group – In the fight against cancer, a political stumbling block was recently put in place by the US Congress after it voted against the renewal of funding for President Biden’s “Cancer...

ONCY : 1.1100 (-1.77%)
ONC.TO : 1.51 (-2.58%)
CADL : 11.50 (-9.45%)
AZN : 76.90 (-0.18%)
HALO : 44.71 (-1.50%)
JANX : 47.10 (-0.86%)
AstraZeneca COVID Vaccine
AstraZeneca pulls its COVID-19 vaccine from the European market Associated Press - Wed May 8, 7:28PM CDT

The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled

$SPX : 5,303.27 (+0.12%)
$DOWI : 40,003.59 (+0.34%)
$IUXX : 18,546.23 (-0.06%)
AZN.LN : 12,110.002 (-0.46%)
AZN : 76.90 (-0.18%)
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024 FinancialNewsMedia - Wed May 8, 8:01AM CDT

EQNX::TICKER_START (OTCPK:MUSLF),(CSE:MUSL),(NYSE:MRK),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:AZN) EQNX::TICKER_END

MUSLF : 0.1852 (-3.69%)
MUSL.CN : 0.2550 (-1.92%)
MRK : 131.19 (+0.24%)
PFE : 28.64 (-0.97%)
MRNA : 132.90 (+0.17%)
AZN : 76.90 (-0.18%)
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024 GlobeNewswire - Wed May 8, 7:30AM CDT

MUSLF : 0.1852 (-3.69%)
MUSL.CN : 0.2550 (-1.92%)
MRK : 131.19 (+0.24%)
PFE : 28.64 (-0.97%)
MRNA : 132.90 (+0.17%)
AZN : 76.90 (-0.18%)
Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032 Newswire.ca - Fri May 3, 11:15AM CDT

/CNW/ -- According to a "highly troubling" new study, the rising number of cancer cases in young people is being attributed to "accelerated aging." Further...

ONCY : 1.1100 (-1.77%)
CELC : 16.76 (-5.10%)
OLMA : 9.84 (+1.86%)
BIO : 293.85 (-0.64%)
AZN : 76.90 (-0.18%)
ONC.TO : 1.51 (-2.58%)
Biotech's Developments in Race Against Rising Cancer Rates Revealed BayStreet.ca - Fri May 3, 10:46AM CDT

USA News Group – According to a “highly troubling” new study, the rising number of cancer cases in young people is being attributed to “accelerated aging.” Further alarm is being spread by the...

ONCY : 1.1100 (-1.77%)
ONC.TO : 1.51 (-2.58%)
CELC : 16.76 (-5.10%)
OLMA : 9.84 (+1.86%)
BIO : 293.85 (-0.64%)
AZN : 76.90 (-0.18%)
Dividends - iStock-184030710
Is This Dividend Stock a Buy Now? Barchart - Fri May 3, 10:14AM CDT

With a robust portfolio, this top pharma stock is a good mix of growth and income.

AZN : 76.90 (-0.18%)
$SPX : 5,303.27 (+0.12%)

Barchart Exclusives

NVDA Earnings, Fed Speakers and Other Key Things to Watch This Week Barchart - Sun May 19, 2:00PM CDT
There was some wild volatility last week as PPI came in hotter than expected and CPI came in just under expectations on the monthly basis. This small decrease in the inflation rate was enough for Fed heads to start talking about rate cuts again the next day. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot